Refine
Has Fulltext
- yes (119)
Is part of the Bibliography
- yes (119)
Year of publication
Document Type
- Journal article (119) (remove)
Keywords
- metabolism (8)
- apoptosis (6)
- SARS-CoV-2 (5)
- cytokinins (5)
- COVID-19 (4)
- regulation (4)
- transcriptome (4)
- Candida albicans (3)
- bioinformatics (3)
- cisplatin (3)
- database (3)
- expression (3)
- identification (3)
- leukemic cells (3)
- molecular docking (3)
- mutation (3)
- systems biology (3)
- virulence (3)
- "-omics" (2)
- Aspergillus fumigatus (2)
- Bioinformatik (2)
- Biology (2)
- Caenorhabditis elegans (2)
- DNA (2)
- DNA storage (2)
- Metabolic pathways (2)
- RNA (2)
- Salmonella-containing vacuole (SCV) (2)
- Staphylococcus aureus (2)
- adaptation (2)
- algorithm (2)
- alignment (2)
- annotation (2)
- cellular signalling networks (2)
- cytotoxicity (2)
- dendritic cells (2)
- differentiation (2)
- drug repurposing (2)
- engineering (2)
- evolution (2)
- infection (2)
- lung cancer (2)
- machine learning (2)
- metabolic modeling (2)
- molecular dynamics (2)
- mouse (2)
- oncolytic virus (2)
- oxidative stress (2)
- platelet (2)
- positive selection (2)
- recombination (2)
- resistance (2)
- synthetic biology (2)
- transcriptional regulation (2)
- 3D lung tumor tissue models (1)
- 3D tissue models (1)
- 6-benzylaminopurine (1)
- A2a-R receptor (1)
- ACKR4 (1)
- AIModules (1)
- AKT (1)
- Abstandsmessung (1)
- Aspergillus (1)
- Aspergillus fumigalus (1)
- Axl tyrosine kinase (1)
- B-cell (1)
- BRAF mutation (1)
- Berberine (1)
- Biologie (1)
- Boolean function (1)
- Boolean tree (1)
- C-60 fullerene (1)
- C60 fullerene (1)
- CD95 (1)
- CETCH cycle (1)
- CLAVATA3 (1)
- CLV3p (1)
- CO2-sequestration (1)
- C\(_{60}\) fullerene (1)
- Camponotus floridanus (1)
- Cell surface proteomics (1)
- Cestode (1)
- Chagas diagnosis (1)
- Chagas disease (1)
- Chagas monitoring (1)
- Chagas real time PCR (1)
- Chlamydia trachomatis (1)
- Computer modelling (1)
- Computer software (1)
- Cushing’s disease (1)
- DLS and AFM measurements (1)
- DNA damage (1)
- Doxorubicin (1)
- EMT (1)
- ERK signaling (1)
- Echinococcosis (1)
- Echinococcus (1)
- Einfluss (1)
- Embryonic induction (1)
- Enterobacteriaceae (1)
- Enzyme kinetics (1)
- Enzyme metabolism (1)
- Enzyme regulation (1)
- Enzymes (1)
- Epicardium-derived cells (1)
- Evaluation (1)
- FLS2 receptor (1)
- Functional modules (1)
- GPVI (1)
- Gene expression vectors (1)
- H7N9 influenza virus (1)
- HGPS (1)
- HIV (1)
- HeLa cells (1)
- Host-parasite interaction (1)
- Human atrial stromal cells (1)
- ICEP (1)
- ICP27 (1)
- IGFBP2 (1)
- Insulin (1)
- Integrated network analysis (1)
- IronChip Evaluation Package (1)
- KRAS biomarker signatures (1)
- Ki67 (1)
- Kinase inhibitor (1)
- Klimaneutralität (1)
- Klimapflanzen (1)
- Klimawandel (1)
- LS-MIDA (1)
- MHC I (1)
- MHC II (1)
- MITE (1)
- Metabolic profiles (1)
- Microarray (1)
- Mikroarray (1)
- Milnesium tardigradum (1)
- Mycoplasma (1)
- Neuromuscular junctions (1)
- Olea (1)
- Phylogenie (1)
- PknB (1)
- Polymerase chain reaction (1)
- Predictive toxicology (1)
- Prognose (1)
- Proteasen (1)
- Proteine (1)
- R0 (1)
- RNA secondary structure (1)
- RNA sequencing (1)
- RNA-SEQ (1)
- RNAi (1)
- Receptor kinase (1)
- Salmonella enterica (1)
- Salmonella-containing vacuole (1)
- Sanger sequencing (1)
- Septins (1)
- Shotgun method (1)
- Spumaviren (1)
- Stp (1)
- Strukturanalyse (1)
- Synapses (1)
- Synaptic vesicles (1)
- Synthetic biology (1)
- T-cell (1)
- T-cell epitope (1)
- Tapeworm (1)
- Toxicity (1)
- Transcriptional control (1)
- Trend test (1)
- Trypanosoma (1)
- Trypanosoma cruzi (1)
- UV–Vis (1)
- V1–V9 (1)
- V4 (1)
- V7/V8 (1)
- VASP (1)
- Vasodilatator-stimuliertes Phosphoprotein (1)
- Vesicles (1)
- Virtual sequencing (1)
- WNT (1)
- Yolk protein (1)
- Zebrafish (1)
- Zika virus (1)
- abscisic acid (ABA) (1)
- accumulation (1)
- adaption (1)
- agent-based model (1)
- aging (1)
- alveolar fibrosis (1)
- alveolar regeneration (1)
- alzheimer's disease (1)
- alzheimers disease (1)
- animals (1)
- anti-cancer drug-like molecules (1)
- anti-thrombotic therapies (1)
- anticancer activity (1)
- antimicrobial peptides (1)
- antimycotics (1)
- antioxidants (1)
- antiproliferative (1)
- approved drugs (1)
- arabidopsis thaliana (1)
- arabidpsis thaliana (1)
- auxin (1)
- bacterial invasion (1)
- bacterial pathogens (1)
- bacteriology (1)
- beta-lactamase inhibition (1)
- binary decision diagram (1)
- binding pocket (1)
- binding protein (1)
- biofilm formation (1)
- biofuel (1)
- bioinformatics and computational biology (1)
- biological activities (1)
- biomanufacturing (1)
- biomarker (1)
- biomaterial surfaces (1)
- bioreactor culture (1)
- blood platelets (1)
- boolean in silico models (1)
- boolean modeling (1)
- brain (1)
- caenorhabditis elegans (1)
- calcium (1)
- calcium signaling pathway (1)
- camponotus floridanus (1)
- cancer therapy (1)
- candida genome database (1)
- carboxylation (1)
- carpenter ant (1)
- cascade (1)
- caspase-3 (1)
- cell death (1)
- cell staining (1)
- cell wall (1)
- centrality (1)
- cerebral ischemia (1)
- chemical similarity (1)
- chondrosarcoma (1)
- cluster (1)
- collagen (1)
- colony-stimulating factor (1)
- colorectal cancer (1)
- combinatorial drug predictions (1)
- comparative sequence analysis (1)
- complex networks (1)
- computational (1)
- computational biology and bioinformatics (1)
- computational modelling (1)
- computational prediction (1)
- computational systems biology (1)
- computer modelling (1)
- computer-assisted (1)
- connector (1)
- control group (1)
- control profiles (1)
- controllability (1)
- corticotropin-releasing hormone (1)
- crosstalk (1)
- cryptic (1)
- culture (1)
- cycle (1)
- cyclic nucleotide signaling (1)
- cytokines (1)
- cytokinin (1)
- cytokinin kinetin (1)
- data mining/methods (1)
- data storage (1)
- defense and evasion strategies (1)
- defense signaling (1)
- defenses (1)
- design (1)
- deubiquitinases (1)
- differentially expressed genes (1)
- discovery (1)
- disease (1)
- docking (1)
- domain (1)
- doxorubicin (1)
- drosophila (1)
- drug design (1)
- drug release (1)
- drug resistance (1)
- drug-minded protein (1)
- dynamic protein-protein interactions (1)
- early diagnosis (1)
- efficient intervention points (1)
- elementary body (1)
- elementary modes (1)
- encapsulation (1)
- encephalitis dementia (1)
- enteric pathogens (1)
- enterica serovar Typhimurium (1)
- enzyme (1)
- epitope mapping (1)
- epitope prediction (1)
- error (1)
- error-transfer (1)
- eugenol (1)
- evolutionary (1)
- exome (1)
- explainability of machine learning (1)
- expressed sequence tag (1)
- extracellular matrix (1)
- facultatively intracellular pathogens (1)
- feature analysis (1)
- feature selection (1)
- flg22 (1)
- fluorescence recovery after photobleaching (1)
- flux balance analysis (1)
- format (1)
- fostamatinib (1)
- free energy (1)
- functional modules (1)
- fungal pathogens (1)
- fungicide (1)
- gamma (1)
- gene expression (1)
- gene ontology (1)
- genes (1)
- genetic regulatory network (1)
- genetic variation (1)
- genetics (1)
- genome browser (1)
- genus Aspergillus (1)
- guard cells (1)
- heart (1)
- hepatotoxicity (1)
- histidine kinase (1)
- homology modeling (1)
- host-pathogen adaption (1)
- host-pathogen interaction (1)
- human (1)
- human immune system (1)
- human immunodeficiency virus (1)
- human pathogenic fungi (1)
- human xenografted mouse models (1)
- humans (1)
- image processing (1)
- imaging (1)
- immune system (1)
- immune-informatics (1)
- immunity (1)
- immunological cross-talk (1)
- immunotherapies (1)
- in silico simulation (1)
- in vitro (1)
- in vivo toxicity (1)
- in-vitro (1)
- infected-cell protein (1)
- infection biology (1)
- infection spread (1)
- inflammation (1)
- inhibitor (1)
- interaction (1)
- interaction map (1)
- interaction networks (1)
- interactome (1)
- intermediate host (1)
- internal transcribed spacer 2 (1)
- interolog (1)
- interpolation (1)
- interspecies comparison (1)
- invasion (1)
- invasiveness (1)
- ion signaling (1)
- isotopolog profiling (1)
- kinase signaling (1)
- kinetin (1)
- lactate dehydrogenase (1)
- lethality rate (1)
- life-span regulation (1)
- light-gated proteins (1)
- lncRNAs (1)
- lymphocytes (1)
- lymphotoxicity (1)
- mammalian system (1)
- messenger RNA (1)
- meta-data (1)
- meta-transcriptome (1)
- metabolic flux (1)
- metabolic modelling (1)
- metabolic pathways (1)
- metabolomic profiling (1)
- miRNAs (1)
- microRNAs (1)
- microRNA–target interaction (1)
- microarray (1)
- microbes (1)
- model reduction (1)
- modeling (1)
- models (1)
- modular tumor tissue models (1)
- modulatory effects (1)
- molecular cloning (1)
- molecular dynamics simulation (1)
- molecular evolution (1)
- molecular modeling (1)
- molecular systematics (1)
- mortality (1)
- mosquito (1)
- mouse model (1)
- myocardial infarction (1)
- myocardium (1)
- nanocarrier (1)
- nanocellulose (1)
- nanocomplex (1)
- natural language processing (1)
- natural processing (1)
- neisseria meningitidis (1)
- network (1)
- network analysis (1)
- network biology (1)
- network inference (1)
- network simulation (1)
- neuraminidase (1)
- neutrophils (1)
- next generation sequencing (1)
- nitric oxide (1)
- non-invasive biomarkers (1)
- noncovalent complex (1)
- noncovalent nanocomplex (1)
- nucleic acid motifs (1)
- olive (1)
- omics (1)
- optimal drug combination (1)
- optimal drug targeting (1)
- optimal pharmacological modulation (1)
- optimal treatment strategies (1)
- optogenetics (1)
- organogenesis (1)
- origin (1)
- pH (1)
- pangolin (1)
- parasite (1)
- pathogen-host interaction (PHI) (1)
- pathogenesis (1)
- pathogenicity (1)
- pathways (1)
- patient data (1)
- pharmacology (1)
- phosphoproteome (1)
- phosphorylation (1)
- photodynamic chemotherapy (1)
- photorespiration (1)
- phylogenetic analysis (1)
- phylogenetic tree (1)
- phylogenetics (1)
- phylogeny (1)
- phytohormones (1)
- plant hormones (1)
- plant system (1)
- pollen tube (1)
- population coverage (1)
- potential role (1)
- principal (1)
- pro-oxidant (1)
- progeria (1)
- promoter (1)
- protease; Indinavir; lead expansion; docking; pharmacophore (1)
- protein (1)
- protein analysis (1)
- protein chip (1)
- protein familiy (1)
- protein interaction database (1)
- protein-protein interaction (1)
- protein-protein interaction network (1)
- proteins (1)
- proteome (1)
- pseudomas-syringae (1)
- pyrazolo[3,4-d]pyrimidine (1)
- radiation (1)
- rational drug design (1)
- re-annotation (1)
- receptor (1)
- regulatory networks (1)
- relA (1)
- reliability (1)
- reproductive toxicity (1)
- response regulator (1)
- reticulate body (1)
- ribosomal RNA (1)
- riboswitch (1)
- richtersius coronifer (1)
- scaffold search (1)
- secondary structure (1)
- sensor (1)
- sequence (1)
- sequence alignment (1)
- shoot apical meristem (1)
- signaling (1)
- signaling network (1)
- signaling pathway (1)
- signalling (1)
- signalling pathways (1)
- silico model (1)
- simulation (1)
- single cell analysis (1)
- single-electron transistors (1)
- sky kinases (1)
- software (1)
- somatic mutations (1)
- spanlastic (1)
- splicing factors (1)
- stable state (1)
- stable-isotope (1)
- stem cell niche (1)
- stem-cell-triggered immunity (1)
- stemness (1)
- stratification (1)
- stringent response (1)
- structure (1)
- structure-activity relationship (1)
- sun exposure (1)
- superoxide-dismutase (1)
- synaptic vesicles (1)
- synergistic effect (1)
- synthetic pathways (1)
- system inference (1)
- tardigrada (1)
- target (1)
- targeted combination therapy (1)
- targeted therapy (1)
- targets (1)
- therapeutic strategy (1)
- thrombosis (1)
- tolerance (1)
- tools overview (1)
- transcription (1)
- translation (1)
- transmission (1)
- tumors (1)
- type 1 (1)
- uptake (1)
- variable regions (1)
- variants (1)
- virulenceregulatory evolution (1)
- viruses (1)
- vitellogenin (1)
- water stress (1)
- wrong labelling (1)
- xanthurenic acid (1)
- yvcK/glmR operon (1)
Institute
- Theodor-Boveri-Institut für Biowissenschaften (117)
- Klinik und Poliklinik für Anästhesiologie (ab 2004) (6)
- Institut für Molekulare Infektionsbiologie (5)
- Lehrstuhl für Tissue Engineering und Regenerative Medizin (5)
- Center for Computational and Theoretical Biology (4)
- Institut für Experimentelle Biomedizin (4)
- Institut für Pharmakologie und Toxikologie (4)
- Institut für Virologie und Immunbiologie (4)
- Kinderklinik und Poliklinik (3)
- Institut für Humangenetik (2)
Sonstige beteiligte Institutionen
EU-Project number / Contract (GA) number
- 031A408B (1)
- CoG 721016–HERPES (1)
- ESF-ZDEX 4.0 (1)
Cushing’s disease (CD) is a rare condition caused by adrenocorticotropic hormone (ACTH)-producing adenomas of the pituitary, which lead to hypercortisolism that is associated with high morbidity and mortality. Treatment options in case of persistent or recurrent disease are limited, but new insights into the pathogenesis of CD are raising hope for new therapeutic avenues. Here, we have performed a meta-analysis of the available sequencing data in CD to create a comprehensive picture of CD’s genetics. Our analyses clearly indicate that somatic mutations in the deubiquitinases are the key drivers in CD, namely USP8 (36.5%) and USP48 (13.3%). While in USP48 only Met415 is affected by mutations, in USP8 there are 26 different mutations described. However, these different mutations are clustering in the same hotspot region (affecting in 94.5% of cases Ser718 and Pro720). In contrast, pathogenic variants classically associated with tumorigenesis in genes like TP53 and BRAF are also present in CD but with low incidence (12.5% and 7%). Importantly, several of these mutations might have therapeutic potential as there are drugs already investigated in preclinical and clinical setting for other diseases. Furthermore, network and pathway analyses of all somatic mutations in CD suggest a rather unified picture hinting towards converging oncogenic pathways.
To enable a sustainable supply of chemicals, novel biotechnological solutions are required that replace the reliance on fossil resources. One potential solution is to utilize tailored biosynthetic modules for the metabolic conversion of CO2 or organic waste to chemicals and fuel by microorganisms. Currently, it is challenging to commercialize biotechnological processes for renewable chemical biomanufacturing because of a lack of highly active and specific biocatalysts. As experimental methods to engineer biocatalysts are time- and cost-intensive, it is important to establish efficient and reliable computational tools that can speed up the identification or optimization of selective, highly active, and stable enzyme variants for utilization in the biotechnological industry. Here, we review and suggest combinations of effective state-of-the-art software and online tools available for computational enzyme engineering pipelines to optimize metabolic pathways for the biosynthesis of renewable chemicals. Using examples relevant for biotechnology, we explain the underlying principles of enzyme engineering and design and illuminate future directions for automated optimization of biocatalysts for the assembly of synthetic metabolic pathways.
Tardigrades have fascinated researchers for more than 300 years because of their extraordinary capability to undergo cryptobiosis and survive extreme environmental conditions. However, the survival mechanisms of tardigrades are still poorly understood mainly due to the absence of detailed knowledge about the proteome and genome of these organisms. Our study was intended to provide a basis for the functional characterization of expressed proteins in different states of tardigrades. High-throughput, high-accuracy proteomics in combination with a newly developed tardigrade specific protein database resulted in the identification of more than 3000 proteins in three different states: early embryonic state and adult animals in active and anhydrobiotic state. This comprehensive proteome resource includes protein families such as chaperones, antioxidants, ribosomal proteins, cytoskeletal proteins, transporters, protein channels, nutrient reservoirs, and developmental proteins. A comparative analysis of protein families in the different states was performed by calculating the exponentially modified protein abundance index which classifies proteins in major and minor components. This is the first step to analyzing the proteins involved in early embryonic development, and furthermore proteins which might play an important role in the transition into the anhydrobiotic state.
Background
Phytoplankton communities are often used as a marker for the determination of fresh water quality. The routine analysis, however, is very time consuming and expensive as it is carried out manually by trained personnel. The goal of this work is to develop a system for an automated analysis.
Results
A novel open source system for the automated recognition of phytoplankton by the use of microscopy and image analysis was developed. It integrates the segmentation of the organisms from the background, the calculation of a large range of features, and a neural network for the classification of imaged organisms into different groups of plankton taxa. The analysis of samples containing 10 different taxa showed an average recognition rate of 94.7% and an average error rate of 5.5%. The presented system has a flexible framework which easily allows expanding it to include additional taxa in the future.
Conclusions
The implemented automated microscopy and the new open source image analysis system - PlanktoVision - showed classification results that were comparable or better than existing systems and the exclusion of non-plankton particles could be greatly improved. The software package is published as free software and is available to anyone to help make the analysis of water quality more reproducible and cost effective.
Background
Processing and analysis of DNA sequences obtained from next-generation sequencing (NGS) face some difficulties in terms of the correct prediction of DNA sequencing outcomes without the implementation of bioinformatics approaches. However, algorithms based on NGS perform inefficiently due to the generation of long DNA fragments, the difficulty of assembling them and the complexity of the used genomes. On the other hand, the Sanger DNA sequencing method is still considered to be the most reliable; it is a reliable choice for virtual modeling to build all possible consensus sequences from smaller DNA fragments.
Results
In silico and in vitro experiments were conducted: (1) to implement and test our novel sequencing algorithm, using the standard cloning vectors of different length and (2) to validate experimentally virtual shotgun sequencing using the PCR technique with the number of cycles from 1 to 9 for each reaction.
Conclusions
We applied a novel algorithm based on Sanger methodology to correctly predict and emphasize the performance of DNA sequencing techniques as well as in de novo DNA sequencing and its further application in synthetic biology. We demonstrate the statistical significance of our results.
Indinavir (Crivaxan®) is a potent inhibitor of the HIV (human immunodeficiency virus) protease. This enzyme has an important role in viral replication and is considered to be very attractive target for new antiretroviral drugs. However, it becomes less effective due to highly resistant new viral strains of HIV, which have multiple mutations in their proteases. For this reason, we used a lead expansion method to create a new set of compounds with a new mode of action to protease binding site. 1300 compounds chemically diverse from the initial hit were generated and screened to determine their ability to interact with protease and establish their QSAR properties. Further computational analyses revealed one unique compound with different protease binding ability from the initial hit and its role for possible new class of protease inhibitors is discussed in this report.
Central nervous system dysfunction is an important cause of morbidity and mortality in patients with human immunodeficiency virus type 1 (HIV-1) infection and acquired immunodeficiency virus syndrome (AIDS). Patients with AIDS are usually affected by HIV-associated encephalitis (HIVE) with viral replication limited to cells of monocyte origin. To examine the molecular mechanisms underlying HIVE-induced dementia, the GSE4755 Affymetrix data were obtained from the Gene Expression Omnibus database and the differentially expressed genes (DEGs) between the samples from AIDS patients with and without apparent features of HIVE-induced dementia were identified. In addition, protein–protein interaction networks were constructed by mapping DEGs into protein–protein interaction data to identify the pathways that these DEGs are involved in. The results revealed that the expression of 1,528 DEGs is mainly involved in the immune response, regulation of cell proliferation, cellular response to inflammation, signal transduction, and viral replication cycle. Heat-shock protein alpha, class A member 1 (HSP90AA1), and fibronectin 1 were detected as hub nodes with degree values >130. In conclusion, the results indicate that HSP90A and fibronectin 1 play important roles in HIVE pathogenesis.
Retroviral vectors are potent tools for gene delivery and various biomedical applications. To accomplish a gene transfer task successfully, retroviral vectors must effectively transduce diverse cell cultures at different phases of a cell cycle. However, very promising retroviral vectors based on the foamy viral (FV) backbone lack the capacity to efficiently transduce quiescent cells. It is hypothesized that this phenomenon might be explained as the inability of foamy viruses to form a pre-integration complex (PIC) with nuclear import activity in growth-arrested cells, which is the characteristic for lentiviruses (HIV-1). In this process, the HIV-1 central polypurine tract (cPPT) serves as a primer for plus-strand synthesis to produce a “flap” element and is believed to be crucial for the subsequent double-stranded cDNA formation of all retroviral RNA genomes. In this study, the effects of the lentiviral cPPT element on the FV transduction potential in dividing and growth-arrested (G1/S phase) adenocarcinomic human alveolar basal epithelial (A549) cells are investigated by experimental and theoretical methods. The results indicated that the HIV-1 cPPT element in a foamy viral vector background will lead to a significant reduction of the FV transduction and viral titre in growth-arrested cells due to the absence of PICs with nuclear import activity.
Clinical trials of novel therapeutics for Alzheimer’s Disease (AD) have consumed a significant amount of time and resources with largely negative results. Repurposing drugs already approved by the Food and Drug Administration (FDA), European Medicines Agency (EMA), or Worldwide for another indication is a more rapid and less expensive option. Therefore, we apply the scaffold searching approach based on known amyloid-beta (Aβ) inhibitor tramiprosate to screen the DrugCentral database (n = 4,642) of clinically tested drugs. As a result, menadione bisulfite and camphotamide substances with protrombogenic and neurostimulation/cardioprotection effects were identified as promising Aβ inhibitors with an improved binding affinity (ΔGbind) and blood-brain barrier permeation (logBB). Finally, the data was also confirmed by molecular dynamics simulations using implicit solvation, in particular as Molecular Mechanics Generalized Born Surface Area (MM-GBSA) model. Overall, the proposed in silico pipeline can be implemented through the early stage rational drug design to nominate some lead candidates for AD, which will be further validated in vitro and in vivo, and, finally, in a clinical trial.